<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Maria</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Pinto, Fausto J.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Updated Guidelines for Valvular Heart Disease</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2013-08-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">28-29</style></pages><abstract><style  face="normal" font="default" size="100%">Valvular heart disease is not usually regarded as a major public health problem. However, the prevalence of both mitral and aortic valve disease is increasing and is particularly troublesome for individuals aged =75 years [Nkomo VT et al. Lancet 2006]. European Society of Cardiology/European Association for Cardio-Thoracic Surgery Guidelines on the management of valvular heart disease were updated in 2012 [Vahanian A et al. Eur Heart J 2012; Eur J Cardiothorac Surg 2012]. This article discusses some of the major changes that resulted from new evidence regarding risk stratification, diagnostic methods, and therapeutic options.</style></abstract><number><style face="normal" font="default" size="100%">7</style></number><volume><style face="normal" font="default" size="100%">13</style></volume></record></records></xml>